Bayer AG (MEX:BAYNN) Cyclically Adjusted Revenue per Share: MXN839.99 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:BAYNN Bayer AG MEX:BAYNN
41 GF Score
Price MXN912.16
GF Value MXN502.50
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Bayer AG Cyclically Adjusted Revenue per Share?

Bayer AG MEX:BAYNN 41 Cyclically Adjusted Revenue per Share is MXN839.99 as of Jun. 2026. GuruFocus rates MEX:BAYNN with a GF Score™ of 41/100 and a GF Value™ of MXN502.50 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bayer AG's adjusted revenue per share for the three months ended in Jun. 2026 was MXN222.466. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN839.99 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Bayer AG's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -0.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 1.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bayer AG was 3.90% per year. The lowest was -0.60% per year. And the median was 2.10% per year.

As of today (2026-08-08), Bayer AG's current stock price is MXN912.16. Bayer AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN839.99. Bayer AG's Cyclically Adjusted PS Ratio of today is 1.09.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bayer AG was 2.52. The lowest was 0.35. And the median was 1.08.


Bayer AG  (MEX:BAYNN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bayer AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=912.16/839.99
=1.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bayer AG was 2.52. The lowest was 0.35. And the median was 1.08.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bayer AG Cyclically Adjusted Revenue per Share Related Terms


Bayer AG Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Bayer AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG Cyclically Adjusted Revenue per Share Chart

Bayer AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,155.31 1,113.19 954.97 1,135.60 1,093.48

Bayer AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,144.25 1,159.75 1,093.48 1,050.49 839.99

MEX:BAYNN vs LLY, JNJ, ABBV: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted PS Ratio falls into.


MEX:BAYNN
41GF Score
Bayer AG MEX:BAYNN
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bayer AG's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=222.466/131.3638*131.3638
=222.466

Current CPI (Jun. 2026) = 131.3638.

Bayer AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 216.708 101.017 281.810
201612 225.964 101.217 293.266
201703 223.707 101.417 289.764
201706 199.938 102.117 257.201
201709 196.020 102.717 250.688
201712 225.610 102.617 288.811
201803 231.162 102.917 295.056
201806 237.675 104.017 300.161
201809 206.225 104.718 258.701
201812 235.884 104.217 297.327
201903 273.986 104.217 345.353
201906 236.853 105.718 294.312
201909 217.549 106.018 269.559
201912 229.306 105.818 284.664
202003 338.762 105.718 420.943
202006 266.014 106.618 327.756
202009 225.287 105.818 279.675
202012 246.202 105.518 306.508
202103 305.364 107.518 373.089
202106 264.971 108.486 320.849
202109 240.842 109.435 289.103
202112 262.323 110.384 312.182
202203 326.754 113.968 376.629
202206 277.492 115.760 314.895
202209 228.691 118.818 252.839
202212 252.265 119.345 277.670
202303 282.658 122.402 303.352
202306 208.803 123.140 222.747
202309 195.699 124.195 206.996
202312 223.502 123.773 237.209
202403 252.756 125.038 265.543
202406 223.695 125.882 233.437
202409 221.737 126.198 230.814
202412 260.727 127.041 269.598
202503 309.280 127.779 317.956
202506 237.399 128.412 242.856
202509 211.709 129.255 215.163
202512 245.474 129.361 249.275
202603 284.455 131.258 284.684
202606 222.466 131.364 222.466

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN839.99 mean?
Bayer AG (MEX:BAYNN) has a Cyclically Adjusted Revenue per Share of MXN839.99 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bayer AG and its competitors.
Is Bayer AG's Cyclically Adjusted Revenue per Share too high?
Bayer AG's current Cyclically Adjusted Revenue per Share is MXN839.99. Overall, Bayer AG has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bayer AG's Cyclically Adjusted Revenue per Share compare to LLY and JNJ?
Bayer AG's Cyclically Adjusted Revenue per Share of MXN839.99 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bayer AG and its competitors. Bayer AG's current Cyclically Adjusted Revenue per Share is MXN839.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer AG stock overvalued right now?
Based on GuruFocus' analysis, Bayer AG (MEX:BAYNN) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN502.50, compared to a current price of MXN912.16 — trading 81.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN839.99. Bayer AG's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Bayer AG (MEX:BAYNN), the current Cyclically Adjusted Revenue per Share is MXN839.99 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bayer AG (MEX:BAYNN) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of MXN912.16 is trading 81.5% above its estimated GF Value™ of MXN502.50. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for MEX:BAYNN:

  • Cyclically Adjusted Revenue per Share: MXN839.99
  • GF Value™: MXN502.50 vs. price of MXN912.16 (81.5% above fair value)
  • GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the MEX:BAYNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
41GF Score

Get the complete analysis for MEX:BAYNN

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN912.16
Price
MXN502.50
GF Value